Skip to main content

Bank of New York Mellon Corp

Bank

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1390777 NEW YORK, NY

Position in ENTA

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$893,987
-$250,724 QoQ
Shares Held
70,783
-2.5% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 79% Shared 0% None 21%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,725,512 across 270 Biotechnology names. ENTA ranks #177 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ENTA

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $893,987 70,783
2025-12-31 $1,144,711 72,588
2025-09-30 $724,099 60,493
2025-06-30 $419,382 55,474
2025-03-31 $293,928 53,248
2024-12-31 $328,438 57,120
2024-09-30 $602,193 58,127
2024-06-30 $957,715 73,841
2024-03-31 $1,138,319 65,196
2023-12-31 $683,410 72,626
2023-09-30 $1,205,856 107,955
2023-06-30 $3,547,968 165,793
2023-03-31 $6,781,907 167,703
2022-12-31 $7,834,851 168,419
2022-09-30 $9,034,662 174,179
2022-06-30 $7,931,667 167,795
2022-03-31 $13,004,654 182,701
2021-12-31 $14,616,570 195,461
2021-09-30 $10,415,656 183,342
2021-06-30 $7,762,172 176,373
2021-03-31 $9,586,917 194,382
2020-09-30 $9,004,145 196,683
2020-06-30 $9,608,786 191,372
2020-03-31 $9,502,976 184,775